Insider Selling: Billiontoone (NASDAQ:BLLN) CTO Sells $2,163,000.00 in Stock

Billiontoone, Inc. (NASDAQ:BLLN) CTO David Tsao sold 20,000 shares of Billiontoone stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $108.15, for a total transaction of $2,163,000.00. Following the completion of the sale, the chief technology officer directly owned 1,000 shares in the company, valued at approximately $108,150. This represents a 95.24% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Tsao also recently made the following trade(s):

• On Thursday, September 24th, David Tsao sold 3,333 shares of Billiontoone stock. The shares were sold at an average price of $125.00, for a total transaction of $416,625.00.
• On Wednesday, September 9th, David Tsao sold 20,000 shares of Billiontoone stock. The shares were sold at an average price of $98.77, for a total value of $1,975,400.00.
• On Tuesday, August 25th, David Tsao sold 10,000 shares of Billiontoone stock. The stock was sold at an average price of $100.00, for a total transaction of $1,000,000.00.
• On Monday, August 10th, David Tsao sold 10,000 shares of Billiontoone stock. The shares were sold at an average price of $92.86, for a total value of $928,600.00.

Billiontoone Stock Performance

Shares of BLLN opened at $98.09 on Friday. The company has a 50-day simple moving average of $103.57 and a two-hundred day simple moving average of $100.78. The firm has a market capitalization of $4.63 billion and a PE ratio of 140.13. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. Billiontoone, Inc. has a one year low of $61.96 and a one year high of $150.44.

Billiontoone (NASDAQ:BLLN) last released its earnings results on Wednesday, August 5th. The company reported $0.15 EPS for the quarter, hitting the consensus estimate of $0.15. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. The business had revenue of $109.45 million for the quarter. On average, analysts anticipate that Billiontoone, Inc. will post 0.83 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of BLLN. Integrated Wealth Concepts LLC purchased a new position in shares of Billiontoone in the 2nd quarter valued at about $29,000. Family Legacy Financial Solutions LLC acquired a new stake in Billiontoone during the 3rd quarter worth $53,000. MCF Advisors LLC grew its holdings in shares of Billiontoone by 330.8% during the second quarter. MCF Advisors LLC now owns 448 shares of the company’s stock worth $54,000 after purchasing an additional 344 shares during the last quarter. Toth Financial Advisory Corp lifted its stake in Billiontoone by 60.0% in the third quarter. Toth Financial Advisory Corp now owns 800 shares of the company’s stock valued at $85,000 after buying an additional 300 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd purchased a new stake in shares of Billiontoone in the fourth quarter valued at about $230,000.

Analysts Set New Price Targets

Several research firms recently weighed in on BLLN. Zacks Research upgraded Billiontoone from a “strong sell” rating to a “hold” rating in a report on Friday, October 2nd. Guggenheim upped their target price on Billiontoone from $125.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. JPMorgan Chase & Co. cut their price target on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research note on Thursday, August 6th. Canaccord Genuity Group assumed coverage on Billiontoone in a research report on Wednesday, September 2nd. They issued a “buy” rating and a $120.00 target price on the stock. Finally, Wall Street Zen cut Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Seven investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $126.25.

Billiontoone Company Profile

BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company’s platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.

BillionToOne’s primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.